Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysisAndrea Ardizzoni, R. Rosell|JNCI Journal of the National Cancer Institute|2007Cited by 606
Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung CancerJohn R. Eckardt, Graham Ross, Joachim von Pawel et al.|Journal of Clinical Oncology|2007Cited by 384
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trialLucia Del Mastro, Francesco Cognetti, Enrichetta Valle et al.|The Lancet|2015Cited by 201
PTEN status in advanced colorectal cancer treated with cetuximabFrancesca Negri, Andrea Ardizzoni|British Journal of Cancer|2009Cited by 85
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell linesAndrea Cavazzoni, Andrea Ardizzoni|Molecular Cancer|2012Cited by 45